Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
RTW Investments
Biotech
RTW-built biotech's $520M deal for InnoCare, Keymed bispecific
Chinese biotechs InnoCare and KeyMed have sold the international rights to a clinical-stage bispecific to a new company created by RTW Investments.
James Waldron
Jan 21, 2025 4:32am
Kailera launches with $400M series A, 4 Chinese obesity drugs
Oct 1, 2024 8:30am
Flagship CEO says firm has work to do before inking China pacts
Jan 8, 2024 9:05pm
Few biotechs dare to test 'eerie' Wall Street IPO market
May 8, 2023 6:00am
VC firms, biotechs push back on drug pricing reforms
Jul 25, 2022 11:07am
Kyverna locks in Gilead, Intellia for $85M financing
Jan 26, 2022 5:00am
